Atherogenic index of plasma predicts progression of diabetic kidney disease
By
Hong-Mou Shih
Sung-Chen Liu
Kuo-Liong Chien
Hsien-Yu Fan
Ming-Chieh Tsai
Shih-Ming Chuang
June 5, 2026
Clinical Scorecard: Plasma Atherogenic Index as a Predictor for the Advancement of Diabetic Kidney Disease
At a Glance
Category Detail
Condition Key Mechanisms Atherogenic dyslipidemia characterized by elevated triglycerides and low HDL cholesterol (source needed). Target Population Care Setting
Key Highlights
Each standard deviation increase in AIP correlates with a 25% increased risk of albuminuria progression (source needed). The highest quartile of AIP shows over double the risk for albuminuria progression compared to the lowest quartile (source needed). Guideline-Based Recommendations
Diagnosis
Management
M o n i t o r A I P a s a p o t e n t i a l m a r k e r f o r D K D p r o g r e s s i o n r i s k ( s o u r c e n e e d e d ) . Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adults aged 20-91 years with type 2 diabetes.
AIP may serve as a simple marker for assessing DKD progression risk.
Clinical Best Practices
Incorporate AIP measurement in routine evaluations for T2D patients (source needed). Related Resources & Content
